Treatment algorithm for patients with hematologic malignancies and chronic HCV infection in 2016.^aPatient had either spontaneous resolution of acute HCV, false positive anti-HCV, or sustained virologic response posttreatment; ^bSee text; ^cSpecialist on infectious diseases, hepatology, or gastroenterology; and ^dAs recommended in selected cases for patients without cancer as of July 2016.